Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for diabetes management that has demonstrated significant weight loss benefits in clinical trials, with patients losing an average of 15–22% of body weight over 68 weeks. Starting semaglutide injections involves a structured approach to help your body adjust to the medication while minimizing side effects. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, making this therapy accessible across all 50 states without insurance requirements.
Understanding Semaglutide: How the Medication Works
Semaglutide works by activating GLP-1 receptors in your brain and digestive system, which regulate appetite signals and blood sugar control. When you inject semaglutide, it slows how fast your stomach empties food, making you feel fuller longer and reducing overall calorie intake naturally. The medication also increases insulin secretion when blood glucose rises, supporting metabolic balance throughout the day.
Clinical research shows that semaglutide's effects develop gradually over the first 4–8 weeks as your body adapts to the medication. Starting at lower doses allows your system to build tolerance, reducing nausea and other adjustment-related side effects. By week 8, most patients report stable appetite suppression and improved eating patterns without daily discomfort.
Semaglutide Dosing Protocol: Titration and Maintenance
Most semaglutide programs begin with a 0.25 mg weekly injection for four weeks, followed by stepwise increases every 4 weeks (0.5 mg, 1.0 mg, and up to 2.4 mg) based on individual tolerance and weight loss response. This graduated titration schedule allows your body to adapt while minimizing gastrointestinal side effects that sometimes occur at higher doses. Your clinical team monitors your progress and adjusts timing based on how your body responds.
The maintenance dose varies between patients; some achieve their weight loss goals at 1.0 mg weekly, while others benefit from 2.0–2.4 mg weekly dosing. Your dose may need to go up as you progress, but PlexusDx pricing remains flat regardless of dose level, keeping your monthly investment predictable. Once you reach an effective maintenance dose, you'll continue weekly injections indefinitely to sustain weight loss and metabolic benefits.
How to Inject Semaglutide Safely at Home
Semaglutide comes in a pen injector device designed for once-weekly subcutaneous injection into your thigh, abdomen, or upper arm. Before each injection, wash the injection site with soap and water, allow it to air-dry, and rotate injection sites weekly to prevent localized irritation. PlexusDx provides detailed video guides and written instructions with each shipment so you can feel confident administering your medication independently.
Insert the needle at a 90-degree angle into the fatty tissue beneath your skin, push the plunger smoothly, and leave the needle in place for 6 seconds to ensure full medication delivery. Most patients experience minimal discomfort because the needle is very fine (31-gauge), and the injection takes only seconds. Store unopened pens in your refrigerator and keep the current pen at room temperature for up to 30 days after first use.
Managing Side Effects During Your First Month
Nausea is the most commonly reported side effect during the first 2–3 weeks of semaglutide therapy, affecting approximately 25–40% of patients, but typically resolves as your body adjusts. Eating smaller, frequent meals, avoiding high-fat foods, and staying hydrated can reduce nausea intensity significantly. If nausea persists beyond week 4, your PlexusDx clinical team can recommend timing adjustments or temporary supportive strategies.
Other mild side effects may include constipation, fatigue, or mild dizziness during the first few weeks; these effects are temporary and usually disappear by week 4–6. Serious adverse events are rare but include pancreatitis symptoms (severe abdominal pain) or signs of allergic reaction, which require immediate medical attention. PlexusDx provides 24/7 access to clinical support if you experience concerning symptoms or have questions about your treatment.
Personalized Treatment with PlexusDx Precision Peptide Testing
PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway genetic assessment that analyzes key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to map your unique metabolic profile. This test evaluates 14 distinct peptide pathways and 150+ genetic insights that influence how your body responds to semaglutide and other weight loss therapies. Understanding your genetic predispositions helps your clinical team optimize dosing, predict side effect risk, and select the most effective medication for your metabolism.
The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, allowing you to start therapy immediately while gathering personalization data. Results typically arrive within 7–10 days and inform ongoing adjustments to maximize your weight loss success. This science-based approach moves beyond one-size-fits-all medicine toward truly individualized GLP-1 therapy.
PlexusDx Semaglutide Access: Pricing and Enrollment
PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across three commitment tiers, meaning your cost remains consistent regardless of which dose your body requires. No insurance is necessary, no membership fees apply, and HSA/FSA accounts are accepted for payment, making this therapy accessible to patients nationwide. PlexusDx ships to all 50 states using licensed 503A compounding pharmacies, ensuring pharmaceutical quality and safety standards.
Your first order begins with a consultation with PlexusDx clinical staff to assess your health history, current medications, and weight loss goals. After your initial assessment, your medication ships directly to your home with complete injection supplies and detailed usage instructions. Ongoing clinical support is included, and you can reach the PlexusDx team by phone or message during business hours for dosing questions, side effect management, or therapy adjustments.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between Ozempic and compounded semaglutide from PlexusDx?
Ozempic is brand-name semaglutide manufactured by Novo Nordisk and typically requires insurance coverage. PlexusDx offers compounded semaglutide from licensed 503A pharmacies at a lower starting price of $149/month without insurance requirements. Both contain the same active ingredient, but compounded versions provide cost accessibility and no-insurance flexibility for weight loss patients.
How much weight can I expect to lose with semaglutide injections?
Clinical trials show average weight loss of 15–22% of body weight over 68 weeks with semaglutide at the 2.4 mg maintenance dose. Individual results vary based on starting weight, lifestyle factors, adherence, and genetic predispositions assessed by PlexusDx Precision Peptide testing. Consistency with weekly injections and healthy eating habits significantly influence outcomes.
Is semaglutide from PlexusDx FDA-approved?
Semaglutide (the active ingredient) is FDA-approved for diabetes and weight loss. PlexusDx's compounded semaglutide is prepared by licensed 503A compounding pharmacies following FDA-regulated standards but is not itself FDA-approved as a brand product. All medications meet pharmaceutical safety and quality requirements.
What should I do if nausea becomes unbearable during my first week?
Contact PlexusDx clinical support immediately; nausea during week 1 is common but should not be severe. Your team can recommend meal timing adjustments, smaller portion sizes, or ginger supplements to manage symptoms. Rarely, dose adjustment or temporary delay in titration helps—never discontinue without professional guidance.
How does the Precision Peptide Genetic Test help optimize my semaglutide therapy?
The Precision Peptide test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict your metabolic response, side effect risk, and ideal dose range for semaglutide. Results inform personalized dosing schedules and help your PlexusDx team identify whether alternative GLP-1 compounds (like tirzepatide) might work better for your genetics.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss: Can You Take Wegovy and Phentermine at the Same Time?
Navigating Weight Loss and Eye Health: Can You Take Ozempic If You Have Retinopathy?